Henk Doude van Troostwijk

Corporate Officer/Principal at HANSA BIOPHARMA AB

Health Technology

Consumer Services

Profile

Henk Doude van Troostwijk is currently the Chief Commercial Officer & Senior VP at Hansa Biopharma AB since 2019.
Prior to this, he worked as the Director-Oncology & Transplantation at Genzyme Europe BV, General Manager-European Commercial Operations at Raptor Pharmaceuticals Corp., and General Manager-European Commercial Operations at Horizon Pharmaceutical LLC.
He holds an MBA degree from Henley Management College.

Henk Doude van Troostwijk active positions

Companies	Position	Start
HANSA BIOPHARMA AB	Corporate Officer/Principal	01/06/2019

All active positions of Henk Doude van Troostwijk

Former positions of Henk Doude van Troostwijk

Companies	Position	End
Raptor Pharmaceuticals Corp. Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007.	Corporate Officer/Principal	-
Genzyme Europe BV Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands.	Corporate Officer/Principal	-
RAPTOR PHARMACEUTICAL CORP	Corporate Officer/Principal	-

See the detail of Henk Doude van Troostwijk's experience

Training of Henk Doude van Troostwijk

Henley Management College

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Henk Doude van Troostwijk's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
HANSA BIOPHARMA AB	Health Technology

Private companies	3
Raptor Pharmaceuticals Corp. Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007.	Health Technology
Genzyme Europe BV Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands.	Health Technology
Horizon Pharmaceutical LLC Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA.	Health Technology

See company connections